Jasmine Hyman is the assistant beauty editor at Cosmopolitan where she writes about all the best products out there. For this ...
Gilead Sciences, Inc. (Nasdaq: GILD) today announced an agreement with the U.S. government designed to reduce drug costs for Americans, reinforcing the company’s long-standing commitment to U.S.-based ...
With so many lip products on the market, choosing just one feels as complicated as choosing the right boyfriend — and honestly, the tradeoffs are eerily similar. Do I want something to stay with me ...
Gilead Sciences remains a bullish pick, with raised guidance and strong Q3/25 results driving optimism for continued growth. Gilead Sciences' key growth drivers include robust sales from Livdelzi and ...
– Commitment Extends Support to Rising Need in California, North Carolina, New Jersey, Maryland, and Washington, D.C. – The funding focuses on reducing barriers to fresh food in vulnerable communities ...
Fintel reports that on November 13, 2025, Scotiabank initiated coverage of Gilead Sciences (NasdaqGS:GILD) with a Sector Outperform recommendation. Analyst Price Forecast Suggests 3.56% Upside As of ...
For the last several quarters, Gilead Sciences’ earnings calls have been colored by anticipation for the launch of the California drugmaker's long-acting HIV pre-exposure prophylaxis (PrEP) option.
Gilead Sciences has chosen a partner for lenacapavir in the race to develop new low-frequency treatments for HIV. After comparing two phase 1 integrase strand transfer inhibitors, the Bay Area pharma ...
Thanks to new settlement agreements with three generic drug makers, Gilead Sciences has extended the expected life span of its flagship HIV treatment Biktarvy by as many years. Gilead has struck ...
Gilead Sciences has bolted another asset onto the virology engine that powers the company, paying (PDF) Health Hope Pharma $10 million upfront for global rights to a candidate in a limited set of ...
HAS THAT STORY. LANA MCDOWELL IS THE FOUNDER OF BALMER, A LIP BALM COMPANY NAMED AFTER THE CITY SHE FELL IN LOVE WITH AFTER LEAVING HOME. I REALLY FELL IN LOVE WITH THIS CITY, EVEN THOUGH I AM FROM A ...
Gilead Sciences broke ground on its new Pharmaceutical Development and Manufacturing (PDM) Technical Development Center (NTDC) at the company’s Foster City headquarters in California. This milestone ...